mTOR inhibitor versus mycophenolic acid as the primary immunosuppression regime combined with calcineurin inhibitor for kidney transplant recipients: a meta-analysis

BACKGROUND: A number of studies have provided information regarding the risks and benefits of mammalian target of rapamycin inhibitors (mTOR-I) combined with calcineurin inhibitors (CNI) versus mycophenolic acid (MPA). METHODS: Medline, Embase and the Cochrane Central Register of Controlled Trials w...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Xishao, Jiang, Yan, Lai, Xiuxiu, Xiang, Shilong, Shou, Zhangfei, Chen, Jianghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486141/
https://www.ncbi.nlm.nih.gov/pubmed/26126806
http://dx.doi.org/10.1186/s12882-015-0078-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486141/
https://www.ncbi.nlm.nih.gov/pubmed/26126806
http://dx.doi.org/10.1186/s12882-015-0078-5

Ejemplares similares